Publications
- Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab2022 | Second Faculty of Medicine
- Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | Second Faculty of Medicine, First Faculty of Medicine
- Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy2016 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Adoptive T cell therapy in cancer treatment +12013 | Second Faculty of Medicine
- Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria2012 | Second Faculty of Medicine
- Th17 lymphocytes in anti-infectious immunity: What have we learnt from the studies in primary immunodeficiencies?2010 | Second Faculty of Medicine
- Antitumor immunity and vaccination against tumors2010 | Second Faculty of Medicine
- Glucocorticoids Severely Impair Differentiation and Antigen Presenting Function of Dendritic Cells Despite Upregulation of Toll-Like Receptors2006 | Second Faculty of Medicine
Loading network view...